Send me a link:

*Text messaging rates may apply.

 Dow Down 1.88% Nasdaq Down 2.09%

Ariad Pharmaceuticals Inc. (ARIA)

-NMS
5.76 Down 0.36(5.88%) 4:00PM EDT
|After Hours : 5.81 Up 0.05 (0.87%) 7:37PM EDT
Prev Close:6.12
Open:6.03
Bid:5.78 x 2200
Ask:5.86 x 3500
1y Target Est:9.34
Beta:1.22
Next Earnings Date: 6-Aug-14ARIA Earnings announcement
Day's Range:5.76 - 6.14
52wk Range:2.15 - 23.00
Volume:6,308,388
Avg Vol (3m):8,802,770
Market Cap:1.08B
P/E (ttm):N/A
EPS (ttm):-1.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARIADown 5.88%1.08B
NVSDown 1.70%210.93B
PFEDown 1.91%183.07B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.47
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.04
Quarterly EPS Est (Jun-14) :-0.29
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.14

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback